56 related articles for article (PubMed ID: 315868)
1. Diminution of prostate by ergoline derivative VUFB--6638 (Dironyl) in rats.
Ausková M; Rezábek K; Marhan O; Zikán V; Semonský M
Endocrinol Exp; 1979 Sep; 13(3):171-6. PubMed ID: 315868
[TBL] [Abstract][Full Text] [Related]
2. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of lactation by N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea (VUFB-6638)].
Ausková M; Rezábek K; Zikán V; Semonský M
Experientia; 1974 Apr; 30(4):393-4. PubMed ID: 4858213
[No Abstract] [Full Text] [Related]
4. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prolactin secretion in rats with the ergoline derivative deprenon.
Chlebounová J; Seda M; Fingerová H; Rezábek K
Arzneimittelforschung; 1980; 30(6):956-8. PubMed ID: 7191272
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lactation in rats with lysenylr SPOFA(N-(D-6-methyl-8-isoergolenyl) N', N'-diethylcarbamide hydrogen maleate).
Ausková M; Rezábek K; Zikán V; Semonský M
Endocrinol Exp; 1974 Mar; 8(1):51-8. PubMed ID: 4547705
[No Abstract] [Full Text] [Related]
8. Induction of oestrus and ovulation with an ergoline derivative, substance VUFB 6638, an inhibitor of prolaction secretion.
Ausková M; Rezábek K; Zikán V; Semonský M
Physiol Bohemoslov; 1974; 23(5):417-21. PubMed ID: 4278534
[No Abstract] [Full Text] [Related]
9. The relationship between the concentration of prolactin receptor and the responses of the prostate gland and seminal vesicles to ergocryptine.
Keenan EJ; Kemp ED; Ramsey EE; Pearse HA; Hodges CV
Proc West Pharmacol Soc; 1979; 22():73-7. PubMed ID: 229495
[No Abstract] [Full Text] [Related]
10. The effect of the ergoline derivative VUFB-6683 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Experientia; 1973 Oct; 29(10):1262-3. PubMed ID: 4796640
[No Abstract] [Full Text] [Related]
11. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
12. Effects of prolactin on the dorsolateral lobe of the rat prostate gland.
Thomas JA; Manandhar MS
Invest Urol; 1977 Mar; 14(5):398-9. PubMed ID: 845005
[TBL] [Abstract][Full Text] [Related]
13. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the growth reaction of the rat adenohypophysis to oestrogen by an ergoline derivative.
Schreiber B; Pribýl T; Rohácová J
Physiol Bohemoslov; 1973; 22(1):11-7. PubMed ID: 4269742
[No Abstract] [Full Text] [Related]
15. Effect of testosterone, dihydrotestosterone, estradiol, and prolactin on the weight and citric acid content of the lateral lobe of the rat prostate.
Walvoord DJ; Resnick MI; Grayhack JT
Invest Urol; 1976 Jul; 14(1):60-5. PubMed ID: 955852
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
[TBL] [Abstract][Full Text] [Related]
17. Some experimental results with prolactin: an overview of effects on the prostate.
Sandberg AA
Prog Clin Biol Res; 1981; 75B():55-62. PubMed ID: 6119702
[No Abstract] [Full Text] [Related]
18. Effects of prolactin on the weight of testes and sex accessory organ, and serum androgen level during sexual maturation of male rats.
Takagi S
Kitasato Arch Exp Med; 1980 Jun; 53(1-2):69-80. PubMed ID: 7277959
[No Abstract] [Full Text] [Related]
19. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Rose DP; Noonan JJ
Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of lactation in the rat following administration of D-6-methyl-8-ergolin-I-yl-acetic acid-amide tartrate (VUFB-6683)].
Ausková M; Rezábek K; Semonský M
Arzneimittelforschung; 1973 Apr; 23(4):617-8. PubMed ID: 4740246
[No Abstract] [Full Text] [Related]
[Next] [New Search]